Corcept Therapeutics Incorporated (CORT) has agreed to sell 11.0 million common shares in an underwritten public offering of common stock. The company has also granted the underwriter a 30-day option to buy from it up to an additional 1.65 million shares.
Corcept plans to use the net proceeds from the offering to fund research and development activities, including clinical trials, and working capital and for general corporate purposes.
Credit Suisse Securities (USA) LLC is acting as sole book-running manager and underwriter in the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.